知镜 Cognispect · 医学文献与研究工作台

Respiratory syncytial virus (RSV) in Saudi Arabian children: Epidemiological burden, seasonality, and the evolving landscape of prevention.

Basabrain AA, Alkinani AM, Alabdali NA, Yeap CG, Alandijany TA.
Journal of infection and public health · 2026-11-03 · PMID 42987753

文献摘要

Respiratory syncytial virus (RSV) is a major cause of pediatric respiratory disease in Saudi Arabia, particularly among infants during the first six months of life. Saudi studies report RSV detection in approximately 20-26% of hospitalized children with respiratory illness, although estimates vary by population, setting, diagnostic method, and study period. RSV contributes substantially to hospitalization, intensive care admission, mechanical ventilation, and healthcare costs. Circulation is generally seasonal, from autumn to early spring, peaking in December and January, with regional variation and post-COVID-19 shifts. Both RSV-A and RSV-B circulate, highlighting the need for ongoing molecular surveillance. Prevention has historically relied on palivizumab for selected high-risk infants. Emerging strategies, including nirsevimab and maternal prefusion F vaccination, show substantial international effectiveness, although Saudi-specific effectiveness data remain unavailable. Broader infant prevention, strengthened surveillance, locally defined seasonal timing, real-world effectiveness studies, molecular monitoring, and comprehensive economic evaluation are therefore strongly warranted across Saudi Arabia.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。